vs
3M（MMM）与NEOGENOMICS INC（NEO）财务数据对比。点击上方公司名可切换其他公司
3M的季度营收约是NEOGENOMICS INC的31.7倍（$6.0B vs $190.2M）。NEOGENOMICS INC同比增速更快（10.6% vs 1.3%）。3M自由现金流更多（$2.0B vs $-6.5M）。过去两年NEOGENOMICS INC的营收复合增速更高（10.3% vs -1.8%）
3M是美国知名跨国综合企业，业务覆盖工业、劳动者安全防护、消费品等多个领域，总部位于圣保罗郊区的枫木市。公司现有超6万款产品，涵盖胶粘剂、研磨材料、防火防护产品、个人防护装备、窗膜、车漆保护膜、电子连接绝缘材料、汽车养护产品、光学膜等品类。
新基因组公司（NeoGenomics）是美国一家经CLIA认证的临床实验室企业，提供药企服务与信息服务，专注于癌症基因诊断检测，旗下检测服务涵盖细胞遗传学、荧光原位杂交（FISH）、流式细胞术、免疫组化、解剖病理学及分子遗传学等多个领域，为肿瘤相关诊断提供专业支持。
MMM vs NEO — 直观对比
营收规模更大
MMM
是对方的31.7倍
$190.2M
营收增速更快
NEO
高出9.3%
1.3%
自由现金流更多
MMM
多$2.0B
$-6.5M
两年增速更快
NEO
近两年复合增速
-1.8%
损益表 — Q1 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $6.0B | $190.2M |
| 净利润 | $653.0M | — |
| 毛利率 | 40.7% | 43.8% |
| 营业利润率 | 23.2% | -7.1% |
| 净利率 | 10.8% | — |
| 营收同比 | 1.3% | 10.6% |
| 净利润同比 | -41.5% | — |
| 每股收益（稀释后） | $1.23 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MMMNEO
| Q1 26 | $6.0B | — | ||
| Q4 25 | $6.1B | $190.2M | ||
| Q3 25 | $6.5B | $187.8M | ||
| Q2 25 | $6.3B | $181.3M | ||
| Q1 25 | $6.0B | $168.0M | ||
| Q4 24 | $6.0B | $172.0M | ||
| Q3 24 | $6.3B | $167.8M | ||
| Q2 24 | $6.3B | $164.5M |
净利润MMMNEO
| Q1 26 | $653.0M | — | ||
| Q4 25 | $577.0M | — | ||
| Q3 25 | $834.0M | $-27.1M | ||
| Q2 25 | $723.0M | $-45.1M | ||
| Q1 25 | $1.1B | $-25.9M | ||
| Q4 24 | $728.0M | — | ||
| Q3 24 | $1.4B | $-17.7M | ||
| Q2 24 | $1.1B | $-18.6M |
毛利率MMMNEO
| Q1 26 | 40.7% | — | ||
| Q4 25 | 33.6% | 43.8% | ||
| Q3 25 | 41.8% | 42.8% | ||
| Q2 25 | 42.5% | 42.6% | ||
| Q1 25 | 41.6% | 43.6% | ||
| Q4 24 | 51.7% | 44.9% | ||
| Q3 24 | 42.1% | 44.6% | ||
| Q2 24 | 42.9% | 44.1% |
营业利润率MMMNEO
| Q1 26 | 23.2% | — | ||
| Q4 25 | 13.0% | -7.1% | ||
| Q3 25 | 22.2% | -14.4% | ||
| Q2 25 | 18.0% | -26.3% | ||
| Q1 25 | 20.9% | -16.6% | ||
| Q4 24 | 12.2% | -10.7% | ||
| Q3 24 | 20.9% | -12.6% | ||
| Q2 24 | 20.3% | -13.3% |
净利率MMMNEO
| Q1 26 | 10.8% | — | ||
| Q4 25 | 9.4% | — | ||
| Q3 25 | 12.8% | -14.4% | ||
| Q2 25 | 11.4% | -24.9% | ||
| Q1 25 | 18.7% | -15.4% | ||
| Q4 24 | 12.1% | — | ||
| Q3 24 | 21.8% | -10.5% | ||
| Q2 24 | 18.3% | -11.3% |
每股收益（稀释后）MMMNEO
| Q1 26 | $1.23 | — | ||
| Q4 25 | $1.07 | — | ||
| Q3 25 | $1.55 | — | ||
| Q2 25 | $1.34 | — | ||
| Q1 25 | $2.04 | — | ||
| Q4 24 | $1.33 | — | ||
| Q3 24 | $2.48 | — | ||
| Q2 24 | $2.07 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.7B | $159.6M |
| 总债务越低越好 | $10.9B | $341.9M |
| 股东权益账面价值 | $3.3B | $836.6M |
| 总资产 | $35.4B | $1.4B |
| 负债/权益比越低杠杆越低 | 3.29× | 0.41× |
8季度趋势，按日历期对齐
现金及短期投资MMMNEO
| Q1 26 | $3.7B | — | ||
| Q4 25 | — | $159.6M | ||
| Q3 25 | — | $164.1M | ||
| Q2 25 | — | $154.7M | ||
| Q1 25 | — | $346.2M | ||
| Q4 24 | — | $367.0M | ||
| Q3 24 | — | $362.0M | ||
| Q2 24 | — | $355.1M |
总债务MMMNEO
| Q1 26 | $10.9B | — | ||
| Q4 25 | $12.6B | $341.9M | ||
| Q3 25 | $12.6B | — | ||
| Q2 25 | $13.1B | — | ||
| Q1 25 | $13.5B | — | ||
| Q4 24 | $13.0B | $541.1M | ||
| Q3 24 | $13.2B | — | ||
| Q2 24 | $13.1B | — |
股东权益MMMNEO
| Q1 26 | $3.3B | — | ||
| Q4 25 | $4.7B | $836.6M | ||
| Q3 25 | $4.6B | $838.3M | ||
| Q2 25 | $4.3B | $854.0M | ||
| Q1 25 | $4.5B | $888.3M | ||
| Q4 24 | $3.8B | $902.3M | ||
| Q3 24 | $4.6B | $908.2M | ||
| Q2 24 | $3.9B | $915.9M |
总资产MMMNEO
| Q1 26 | $35.4B | — | ||
| Q4 25 | $37.7B | $1.4B | ||
| Q3 25 | $37.6B | $1.4B | ||
| Q2 25 | $38.0B | $1.4B | ||
| Q1 25 | $40.0B | $1.6B | ||
| Q4 24 | $39.9B | $1.6B | ||
| Q3 24 | $40.9B | $1.6B | ||
| Q2 24 | $43.4B | $1.6B |
负债/权益比MMMNEO
| Q1 26 | 3.29× | — | ||
| Q4 25 | 2.68× | 0.41× | ||
| Q3 25 | 2.72× | — | ||
| Q2 25 | 3.06× | — | ||
| Q1 25 | 3.02× | — | ||
| Q4 24 | 3.40× | 0.60× | ||
| Q3 24 | 2.84× | — | ||
| Q2 24 | 3.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $1.3M |
| 自由现金流经营现金流 - 资本支出 | $2.0B | $-6.5M |
| 自由现金流率自由现金流/营收 | 33.6% | -3.4% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $3.7B | $-21.8M |
8季度趋势，按日历期对齐
经营现金流MMMNEO
| Q1 26 | — | — | ||
| Q4 25 | $1.6B | $1.3M | ||
| Q3 25 | $1.8B | $8.9M | ||
| Q2 25 | $-954.0M | $20.3M | ||
| Q1 25 | $-79.0M | $-25.3M | ||
| Q4 24 | $1.8B | $9.8M | ||
| Q3 24 | $-1.8B | $9.2M | ||
| Q2 24 | $1.0B | $13.9M |
自由现金流MMMNEO
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.3B | $-6.5M | ||
| Q3 25 | $1.5B | $570.0K | ||
| Q2 25 | $-1.2B | $14.0M | ||
| Q1 25 | $-315.0M | $-29.8M | ||
| Q4 24 | $1.5B | $-1.8M | ||
| Q3 24 | $-2.0B | $-1.6M | ||
| Q2 24 | $752.0M | $814.0K |
自由现金流率MMMNEO
| Q1 26 | 33.6% | — | ||
| Q4 25 | 21.8% | -3.4% | ||
| Q3 25 | 23.6% | 0.3% | ||
| Q2 25 | -18.3% | 7.7% | ||
| Q1 25 | -5.3% | -17.8% | ||
| Q4 24 | 25.4% | -1.0% | ||
| Q3 24 | -32.3% | -0.9% | ||
| Q2 24 | 12.0% | 0.5% |
资本支出强度MMMNEO
| Q1 26 | — | — | ||
| Q4 25 | 4.0% | 4.1% | ||
| Q3 25 | 3.3% | 4.4% | ||
| Q2 25 | 3.3% | 3.5% | ||
| Q1 25 | 4.0% | 2.7% | ||
| Q4 24 | 4.8% | 6.7% | ||
| Q3 24 | 3.9% | 6.4% | ||
| Q2 24 | 4.3% | 8.0% |
现金转化率MMMNEO
| Q1 26 | — | — | ||
| Q4 25 | 2.74× | — | ||
| Q3 25 | 2.11× | — | ||
| Q2 25 | -1.32× | — | ||
| Q1 25 | -0.07× | — | ||
| Q4 24 | 2.50× | — | ||
| Q3 24 | -1.30× | — | ||
| Q2 24 | 0.89× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MMM
| Safety and Industrial business segment | $2.9B | 49% |
| Transportation and Electronics business segment | $1.8B | 31% |
| Consumer business segment | $1.1B | 19% |
| Corporate | $121.0M | 2% |
NEO
| Client Direct Billing | $133.4M | 70% |
| Commercial Insurance | $31.4M | 17% |
| Medicare And Other Governmental | $25.4M | 13% |
